Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Earth Corporation currently has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 3 actions are distributed across 3 distinct examiners and 3 distinct art units. This distribution shows that each pending matter is being reviewed in a different technical environment. MILLER, MAKENNA RYLEIGH is the busiest examiner with 1 pending action. Because each of the 3 pending office actions is assigned to a different examiner, the company must manage multiple sets of examiner expectations and prosecution styles simultaneously.
The presence of 3 distinct art units suggests that the company's biotechnology innovations are being reviewed by several specialized technical groups at the USPTO. This distribution means that the prosecution risk is spread across different administrative units, rather than being concentrated in a single art unit. For practitioners, this requires a strategy that can adapt to the specific precedents and examination standards of the different art units involved. With the workload split among 3 distinct examiners, the company's immediate patenting success is not dependent on any single individual, but rather on the outcomes of independent review processes. This lack of examiner concentration can lead to varying timelines for the pending office actions currently in the pipeline.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MILLER, MAKENNA RYLEIGH | 1 | 100.0% | +0.0% |
| BREDEFELD, RACHAEL EVA | 1 | 27.4% | +35.0% |
| PETRITSCH, AMANDA MICHELLE | 1 | 57.1% | +28.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18851464 | COMPOSITION | MILLER, MAKENNA RYLEIGH | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18005552 | ORAL CARE AGENT | PETRITSCH, AMANDA MICHELLE | 86d overdue |
| 18686241 | COMPOSITION | BREDEFELD, RACHAEL EVA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18005552 | ORAL CARE AGENT | PETRITSCH, AMANDA MICHELLE | 86d overdue |
| 18686241 | COMPOSITION | BREDEFELD, RACHAEL EVA | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| 3786 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18851464 | COMPOSITION | MILLER, MAKENNA RYLEIGH | 1611 | §103DP | Final Rejection | — | Pending | Sep 26, 2024 |
| 18686241 | COMPOSITION | BREDEFELD, RACHAEL EVA | 3786 | §103 | Final Rejection | — | Pending | Feb 23, 2024 |
| 18005552 | ORAL CARE AGENT | PETRITSCH, AMANDA MICHELLE | 1612 | §103§112 | Final Rejection | 86d overdue | Pending | Jan 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial